Eli Lilly, one of the world’s largest pharmaceutical companies, invites designers and developers to re-imagine clinical trial information in a patient-centric way. As part of Lilly’s Clinical Open Innovation initiative, which calls on open innovation to help transform clinical research and development, challenge participants are now being asked to focus on the ideas and possibilities for envisioning clinical trial protocols from a patient’s point of view.

Clinical trial information can often be dense and difficult to digest from a patient’s perspective. Patients may have questions surrounding the risks and benefits of their participation in the trial, logistics, the role of their personal doctor, and much more.  The goal for this challenge is to redesign that information in a way that highlights key aspects in a visually appealing and user-friendly way.

Submissions will take the form of design mockups and participants will be asked to submit one or more images, or browser viewable files, that incorporate key sections found in the Required Sections and Fields document and also use content data from the provided sample clinical trial documents.

Click “Register” for submission requirements and eligibility details.

$75,000 in prizes

1. Click “Register” to sign up for important challenge updates.
2. Review the Resources page to get access to the Required Sections and Fields document and the required content.
3. Create your design (Acceptable formats: PNG, JPG, GIF – non-animated, TIFF, PSD, AI, PDF, or HTML.)
4. Confirm you have read and agree to the Official Rules and are releasing your design to the public under the Creative Commons Attribution 3.0 Unported License, then submit your design by completing the submission form.

• Visual Presentation
  Includes visual appeal, and whether the hierarchy and density of information is user-friendly and digestible.
• Patient Usefulness
  Includes whether the design highlights information valuable to patients and assists them in options for their next steps in health care.
• Appropriateness for Mobile or Web Application
  Includes the potential to implement the design as a mobile or web app.
• Potential Impact on Clinical Trials
  Includes the extent to which the submission may enrich the clinical trial experience for patients, caregivers, and medical institutions.